These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22438210)

  • 1. Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.
    Eisenhofer G; Vocke CD; Elkahloun A; Huynh TT; Prodanov T; Lenders JW; Timmers HJ; Benhammou JN; Linehan WM; Pacak K
    Horm Metab Res; 2012 May; 44(5):343-8. PubMed ID: 22438210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
    Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K
    Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal paraganglioma with loss of heterozygosity of the von Hippel-Lindau gene: a case report and review of the literature.
    Anno M; Izawa S; Fujioka Y; Matsuzawa K; Saito K; Hikita K; Makishima K; Nosaka K; Takenaka A; Usui T; Yamamoto K
    Endocr J; 2022 Sep; 69(9):1137-1147. PubMed ID: 35466127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene.
    Sansó G; Rudaz MC; Levin G; Barontini M
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1107-11. PubMed ID: 15607616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.
    Hasani-Ranjbar S; Amoli MM; Ebrahim-Habibi A; Haghpanah V; Hejazi M; Soltani A; Larijani B
    Fam Cancer; 2009; 8(4):465-71. PubMed ID: 19649731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.
    Rich TA; Jonasch E; Matin S; Waguespack SG; Gombos DS; Santarpia L; Stolle C; Jimenez C
    Cancer Invest; 2008 Jul; 26(6):642-6. PubMed ID: 18584357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene.
    Cybulski C; Krzystolik K; Murgia A; Górski B; Debniak T; Jakubowska A; Martella M; Kurzawski G; Prost M; Kojder I; Limon J; Nowacki P; Sagan L; Białas B; Kałuza J; Zdunek M; Omulecka A; Jaskólski D; Kostyk E; Koraszewska-Matuszewska B; Haus O; Janiszewska H; Pecold K; Starzycka M; Słomski R; Cwirko M; Sikorski A; Gliniewicz B; Cyryłowski L; Fiszer-Maliszewska Ł; Gronwald J; Tołoczko-Grabarek A; Zajaczek S; Lubiński J
    J Med Genet; 2002 Jul; 39(7):E38. PubMed ID: 12114495
    [No Abstract]   [Full Text] [Related]  

  • 11. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
    Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG
    Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.
    Lomte N; Kumar S; Sarathi V; Pandit R; Goroshi M; Jadhav S; Lila AR; Bandgar T; Shah NS
    Fam Cancer; 2018 Jul; 17(3):441-449. PubMed ID: 29124493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering a novel genetic variant in 11 family members who had isolated pheochromocytoma linked to von Hippel-Lindau (VHL) syndrome, aligning with the type 2c phenotype.
    Alhawari H; Obeidat Z; Wahbeh L; Mismar A; Younis N; Jafar H; Momani M; Alsabatin N; Awidi A; Alhawari H
    Blood Press; 2024 Dec; 33(1):2355268. PubMed ID: 38824681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the Von Hippel-Lindau (VHL) gene in a family with non-syndromic pheochromocytoma: the importance of genetic testing.
    Cruz JB; Fernandes LP; Clara SA; Conde SJ; Perone D; Kopp P; Nogueira CR
    Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1463-7. PubMed ID: 18209888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Hippel-Lindau gene mutation in non-syndromic familial pheochromocytomas.
    Tong AL; Zeng ZP; Li HZ; Yang D; Lu L; Li M; Zhou YR; Zhang J; Chen S; Liang W
    Ann N Y Acad Sci; 2006 Aug; 1073():203-7. PubMed ID: 17102088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.
    Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE
    J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.